Feinberg faculty, staff and students participated in lectures, workshops and presentations during the 5th Annual Medical Education Day.
Northwestern Medicine scientists helped develop an implantable device that detects early breast cancer metastatic cells, a method that may enable physicians to identify cancer spreading in patients while treatments are still viable.
Emergency department patients have a range of beliefs and attitudes about the risk of becoming addicted to prescribed opioids, according to a recent study authored by a Feinberg medical student.
Recordings of neurons in a little-studied part of the brain associated with memory show an unexpected increase in activity in older brains, a finding that may suggest a new target for therapies to combat memory loss.
A new study co-authored by a Northwestern Medicine scientist found no significant difference between two popular therapy regimens in patients with a subset of Hodgkin lymphoma.
In a new study, patients treated with one-fourth of the dose of beta-blockers tested in large clinical trials had a 20 to 25 percent increase in survival, indicating that dosing likely needs to be personalized for patients to get the best benefit.
Teresa Mastin, PhD, the new Director of Diversity and Inclusion, joins Feinberg to strengthen and expand diversity and inclusion efforts across the medical school.
Dan Foltz, ’02 PhD, Panagiotis Ntziachristos, PhD, and Marc Mendillo, PhD, have joined the Department of Biochemistry and Molecular Genetics.
At the Fourth Annual Driskill Day, students, faculty members and alumni gathered to present research, recognize achievement and celebrate the Walter S. and Lucienne Driskill Graduate Training Program in Life Sciences.
A new imaging technique that allows for visualization of blood flow in real-time revealed that abnormal blood flow from the two-flap valve in bicuspid aortic valve disease can create weakness in the aorta.